Search

Home > The Evidence Based Rheumatology Podcast > E49: IL17i vs. TNFi for Psoriatic Arthritis (SPIRIT-H2H)
Podcast: The Evidence Based Rheumatology Podcast
Episode:

E49: IL17i vs. TNFi for Psoriatic Arthritis (SPIRIT-H2H)
Category: Health
Duration: 00:10:48
Publish Date: 2019-10-17 17:20:55
Description:

Today I dive into the emerging therapies for psoriatic arthritis, focusing on the IL17i ixekizumab and the recently published SPIRIT-H2H trial. It's a great combination of my favorite thing in RCTs (head to head trials) and my least favorite thing in RCTs (RCTs that were designed in such a way that they don't answer the question I want to know).  
Total Play: 0